Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

Intensity-modulated proton therapy (IMPT) improves overall survival (OS) and reduces high-grade toxicity compared with intensity-modulated radiation ...

In patients with renal cell carcinoma, a phase 2 trial tested neoadjuvant stereotactic ablative radiation therapy to the inferior vena cava tumor thrombus before radical nephrectomy with thrombectomy.

Sun Pharmaceutical Industries Limited has announced that UNLOXCYT (cosibelimab-ipdl) is now available in the United States ...

As of Tuesday, January 13, Sensus Healthcare, Inc.’s SRTS share price has surged by 10.65%, which has investors questioning ...

Learn more about whether Mirion Technologies, Inc. or Nayax Ltd. is a better investment based on AAII's A+ Investor grades, ...

All depth measurements reported are down-hole and true thicknesses are yet to be determined.

All depth measurements reported are down-hole and true thicknesses are yet to be determined.

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

Study Highlights Growing Reliance on Nano-Ceramic Coating for Cars Amid Rising Environmental Stress on Vehicle ...

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

CAS Space conducts first suborbital launch and capsule landing test Chinese commercial firm CAS Space launched its first ...